FisherVista

A World Gold Council survey reveals that 29% of central banks intend to boost their gold reserves in the next year, with 81% expecting global central bank holdings to rise, underscoring gold's enduring appeal despite record prices.

Binance may lose access to the EU market if its MiCA license application is rejected in Greece, impacting investors and the crypto industry.

A court sentenced two individuals for arson attacks on properties linked to UK Prime Minister Sir Keir Starmer, revealing that a Russian-directed network promised cryptocurrency payments to the perpetrators.

The article explains the complex reasons behind multi-year timelines for data center construction, highlighting implications for AI-dependent businesses like GlobalTech Corp.

A new Wood Mackenzie report reveals that the data center boom is driving demand for aluminum and copper beyond current estimates, with significant implications for metal producers and memory manufacturers like Micron.

Spain's investment in renewable infrastructure has led to an average monthly reduction of $11 per household in electricity costs, contrasting with rising bills across Europe due to Middle Eastern conflicts disrupting energy supplies.

Greenland Energy Company (NASDAQ: GLND) is advancing exploration at the Jameson Project in East Greenland, aligning with Greenland’s broader goal of reducing financial dependence through responsible resource development.

Onco-Innovations Limited is featured in a BioMedWire editorial examining the growing market for DNA Damage Response inhibitor therapies, highlighting its lead candidate ONC010 as a nanoparticle-encapsulated PNKP inhibitor targeting DNA repair pathways in precision oncology.

Safe Pro Group released a video showcasing its RoadSight UGV capability, applying patented SPOTD AI technology to autonomous ground vehicles for real-time detection of explosive threats, following a $1.3 million U.S. Army subcontract.

Quantum BioPharma’s first-in-class Lucid-MS drug candidate, designed to protect the myelin sheath in multiple sclerosis, is preparing for Phase 2 trials, addressing a significant unmet need for over 2.9 million patients worldwide.

American Fusion Inc. provided an update on its Texatron Fusion Engine progress, highlighting strong researcher interest at the IEEE ICOPS conference and ongoing discussions with Texas Tech University for testing facilities.

Ladybug Resource Group is leveraging its JingDiao division's high-precision manufacturing model to target medical, aerospace, and semiconductor markets, reducing dependency on the automotive sector and tapping into global reshoring trends.

tZERO and Archax will distribute Archax's $GOVY tokenized US Treasury Bill product to US qualified purchasers through tZERO's SEC- and FINRA-regulated broker-dealer ecosystem, marking the first US availability of the token.

Energy Fuels Inc. agrees to acquire Germany-based Vacuumschmelze for $1.9 billion, creating a fully integrated rare earth supply chain from mining to finished magnets, strengthening Western access to critical materials.

The 7th Clinical Trial Agreements Summit, hosted by Dynamic Global Events, will guide stakeholders in navigating complex clinical trial agreements amid new regulations and technologies.

Safe Pro Group Inc. (NASDAQ: SPAI) has been awarded a $1.3 million U.S. Army subcontract to integrate its proprietary AI threat detection technology into unmanned ground vehicles, enhancing real-time explosive threat identification for military operations.

Momentic introduces an agentic quality platform that uses AI agents to automate software verification, aiming to keep pace with the surge in code production from AI coding tools.

LataMed AI Corp. announced its Venezuelan affiliate will be featured in ES Salud Magazine, discussing its telehealth and AI solutions aimed at improving healthcare accessibility in emerging markets.

A new survey reveals 77% of investors favor maintaining quarterly earnings reports, while public company executives are more divided on the SEC’s proposal to allow semi-annual reporting.

ABVC BioPharma plans to spin off its nutraceutical subsidiary BioKey by distributing 15% of BioKey shares as a dividend, providing shareholders direct participation in BioKey's future growth.

Thailand's FastPass program integrates eight government agencies to cut regulatory approval timelines by up to 50 percent, unlocking over USD 21 billion in strategic high-tech investment and accelerating 101 projects into physical factories.